Home/Filings/4/0001493152-20-018823
4//SEC Filing

Jones Timothy L. 4

Accession 0001493152-20-018823

CIK 0000849636other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 3:51 PM ET

Size

12.6 KB

Accession

0001493152-20-018823

Insider Transaction Report

Form 4
Period: 2020-09-30
Jones Timothy L.
DirectorCEO and President
Transactions
  • Conversion

    Common Stock

    2020-09-30+4,409,0634,409,063 total
  • Conversion

    Series H Preferred Stock

    2020-09-3028.2180 total
    Exercise: $0.01From: 2020-09-30Exp: 2023-09-30Conversion Units (4,409,063 underlying)
  • Other

    Series H Preferred Stock

    2020-09-30+28.21828.218 total
    Exercise: $0.01From: 2020-09-30Exp: 2023-09-30Conversion Units (4,409,063 underlying)
  • Conversion

    Warrants (to purchase Common Stock)

    2020-09-30+4,409,0634,409,063 total
    Exercise: $0.01From: 2020-09-30Exp: 2023-09-30Common Stock (4,409,063 underlying)
Footnotes (4)
  • [F1]On September 30, 2020, Mr. Jones converted his outstanding shares of the Company's Series H 2% Voting, Non-Participating, Convertible Preferred Stock ("Series H Preferred") into 4,409,063 Conversion Units comprising 4,409,063 shares of the common stock of the Company and 4,409,063 warrants exercisable into 4,409,063 shares of the common stock of the Company.
  • [F2]The full designation of this class of preferred stock is "Series H 2% Voting, Non-Participating, Convertible Preferred Stock".
  • [F3]On September 30, 2020, Mr. Jones agreed to forgive a portion of accrued compensation owing from RespireRx Pharmaceuticals Inc. (the "Company") equal to $28,218, and in exchange, the Company issued to Mr. Jones 28.218 shares of Series H Preferred stock, which equates to a per share value of $1,000.00 per share.
  • [F4]Each Conversion Unit ("Conversion Unit") consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023).

Documents

1 file

Issuer

RespireRx Pharmaceuticals Inc.

CIK 0000849636

Entity typeother

Related Parties

1
  • filerCIK 0001812101

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 3:51 PM ET
Size
12.6 KB